𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of HIV protease by monoclonal antibodies

✍ Scribed by P. Rezacova; J. Brynda; M. Fabry; M. Horejsi; R. Stouracova; J. Lescar; V. Chitarra; M. M. Riottot; J. Sedlacek; G. A. Bentley


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
272 KB
Volume
15
Category
Article
ISSN
0952-3499

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The protease of HIV plays a critical role in the maturation of the infectious particles of the virus. The enzyme has therefore been extensively studied with the objective of developing therapeutics that inhibit viral proliferation. We have produced monoclonal antibodies specific for the HIV‐1 protease, and selected those that inhibit enzyme function for use as probes to study the enzyme's activity and as an eventual aid for the development of potential inhibitors targeted to regions other than the active site. We have characterized two such mAbs, F11.2.32 and 1696, which have inhibition constants in the low nanomolar range and which recognize epitopes from different regions of the protease. The crystal structures of the two antibodies, both in the free state as well as complexes with peptide fragments corresponding to their respective epitopes, have been solved. The structural analyses, taken together with other functional data on the antibodies, suggest mechanisms of protease inhibition by these antibodies. Copyright Β© 2002 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Inhibition of HIV-1 infection in vitro b
✍ L. Franke; R. Grunow; K. Meissner; T. Porstmann; R. von Baehr πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 572 KB

## Abstract Murine monoclonal antibodies (Mabs) to the major core protein p24 of the human immunodeficiency virus type 1 (HIV‐1) were tested for their ability to inhibit the replication and spread __of__ the virus in permanent cell cultures (Molt4/8, K37, H9) and in the culture of 11‐2 stimulated T

Preliminary crystallographic studies of
✍ Julien Lescar; Renata Stouracova; Marie-Madeleine Riottot; VΓ©ronique Chitarra; J πŸ“‚ Article πŸ“… 2008 πŸ› Cold Spring Harbor Laboratory Press 🌐 English βš– 300 KB

## Abstract F11.2.32, a monoclonal antibody directed against the HIV‐1 protease, displays strong inhibitory effects toward the catalytic activity of the enzyme. The antibody cross‐reacts with peptides 36–46 and 36–57 from the protease. Crystals of the Fab have been obtained both in the free state a

HIV-1 protease inhibition potential of f
✍ Andreas FlΓΌtsch; Thilo Schroeder; Markus G. GrΓΌtter; Greta R. Patzke πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 577 KB

Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing the